Abstract
INTRODUCTION AND AIMS: Patients with chronic kidney disease (CKD) have increased risk of progressing to end-stage renal disease (ESRD) and a high mortality rate. One of the major underlying causes of progression of renal failure is renal fibrosis, which is caused by dysregulated extracellular matrix (ECM) remodeling. The laminin γ1 (LAMC1) chain is a constituent of the laminin types present in the glomerular basement membrane (GBM), and its turnover may be altered in CKD. Fragments of LAMC1 could quantify GBM turnover in human CKD and reflect pathological tissue changes. We developed an immunoassay targeting LG1M, a neo-epitope of LAMC1 generated by matrix metalloproteinases (MMPs). We then measured LG1M levels in serum and urine from a large prospective cohort of patients with high-risk CKD.
Original language | English |
---|---|
Journal | Nephrology, Dialysis, Transplantation |
Volume | 32 |
Issue number | Suppl. 3 |
Number of pages | 1 |
ISSN | 0931-0509 |
DOIs | |
Publication status | Published - 2017 |
Event | 54th ERA-EDTA Congress - Madrid, Spain Duration: 3 Jun 2017 → 6 Jun 2017 Conference number: 54 http://www.era-edta2017.org/en-US/home |
Conference
Conference | 54th ERA-EDTA Congress |
---|---|
Number | 54 |
Country/Territory | Spain |
City | Madrid |
Period | 03/06/2017 → 06/06/2017 |
Internet address |